ClinicalTrials.gov
public full text
Public Domain
Triple-Blind Randomized Clinical Trial of Tocilizumab vs Placebo: Potential Use of an IL-6 Antagonist as an Adjuvant to Standard Treatment for Treatment-Resistant Major Depression in the Brazilian Public Health System (SUS)
Clinical trial aimed at evaluating whether a single infusion of tocilizumab, a medication that blocks the action of an inflammatory molecule called interleukin-6 (IL-6), can reduce symptoms of treatment-resistant major depression compared to placebo in non-hospitalized patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study Of New Medicine (GSK 372475) For The Treatment Of Depression#1185353
- Effect of Aspirin vs Placebo on the Prevention of Depression in Older People#1242903
- Sertraline as an antidepressant and inflammatory cytokines in depressive disorders : a systematic review and meta-analysis of randomized double-blind placebo-controlled trials#443711
- SSRI Effects on Depression and Immunity in HIV/AIDS#1044325
- Multiple Ascending Dose Phase 1 Study of ALA-3000#888825
Record · ID 1440481
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive